T cell development in the thymus involves two critical selection steps to generate a functional, self-tolerant T cell repertoire. Positive selection retains thymocytes with TCRs that weakly recognize self-MHC on cortical epithelial cells, instructing CD4/CD8 lineage choice. Negative selection eliminates thymocytes with high-affinity TCRs recognizing self-peptide-MHC complexes on medullary epithelial cells and dendritic cells, preventing autoimmunity. ~95% of thymocytes undergo apoptosis during these selections.
Diagram the cortex and medulla showing positive and negative selection compartments and their cellular inhabitants. Explain how TCR signaling strength (weak vs strong) determines selection outcome.
You already know that T cell receptors (TCRs) are generated through random gene rearrangement, producing an enormous diversity of receptors — most of which will be useless or dangerous. The thymus is where this raw repertoire gets quality-controlled through two sequential filters, each testing a different property of the TCR. Think of it as a two-round audition: the first round checks whether you can perform at all, and the second checks whether you will perform safely.
Positive selection occurs in the thymic cortex, where immature thymocytes (still expressing both CD4 and CD8) encounter cortical thymic epithelial cells (cTECs) displaying self-peptides on MHC molecules. The test is simple: can your TCR recognize self-MHC at all? Thymocytes whose TCRs bind self-MHC with weak but detectable affinity receive a survival signal; those that cannot bind — the majority — die by neglect within about three days. This step ensures that every T cell entering the periphery can actually interact with MHC molecules, which is essential because T cells can only "see" antigens presented on MHC. During positive selection, lineage commitment also occurs: thymocytes that bind MHC class II downregulate CD8 and become CD4+ T cells, while those that bind MHC class I downregulate CD4 and become CD8+ T cells.
Negative selection occurs primarily in the thymic medulla, where surviving thymocytes now encounter medullary thymic epithelial cells (mTECs) and dendritic cells presenting a broader array of self-antigens. A remarkable protein called AIRE (autoimmune regulator) drives mTECs to express tissue-specific proteins from organs throughout the body — insulin from the pancreas, myelin from the brain, thyroglobulin from the thyroid — creating a molecular preview of self. Thymocytes whose TCRs bind these self-peptide-MHC complexes with high affinity are deleted through apoptosis, because a T cell that reacts strongly to self would cause autoimmune destruction in the periphery. The critical variable is signal strength: weak binding during positive selection means "functional, keep it," while strong binding during negative selection means "self-reactive, destroy it."
The numbers tell the story of how stringent this quality control is: roughly 95–98% of all thymocytes die during development, most failing positive selection. Of those that pass, a further fraction is eliminated by negative selection. The tiny surviving population — perhaps 2–5% of the original — consists of T cells that can recognize MHC (proven by positive selection) but do not react strongly to self (proven by negative selection). There is one important exception to the deletion rule: some thymocytes with moderately high self-reactivity are diverted into the regulatory T cell (Treg) lineage rather than being killed, providing a population of cells that will actively suppress self-reactive responses in the periphery. This represents an elegant solution — rather than waste every self-reactive cell, the thymus repurposes some of them as immune regulators.